Cite

HARVARD Citation

    Fumet, J. et al. (n.d.). 85PEvaluation of the safety and the tolerability of durvalumab plus tremelimumab combined with FOLFOX in metastatic colorectal cancer (MEDITREME). Annals of oncology. p. . [Online]. 
  
Back to record